The humble office staple, when compressed into a dense, chaotic bundle, exhibits a mechanical paradox that has long intrigued physicists…
Read More
Cornell University Scientists Identify Breakthrough Nonhormonal Path Toward Reversible Long Acting Male Contraception.
In a landmark advancement for reproductive science, researchers at Cornell University have announced a significant breakthrough in the quest for…
Read More
Cornell University Scientists Achieve Breakthrough in Reversible Nonhormonal Male Contraception through Targeted Meiotic Interruption
In a significant advancement for reproductive medicine, researchers at Cornell University have successfully demonstrated a method for a safe, reversible,…
Read More
Cornell University Scientists Identify New Pathway for Reversible Nonhormonal Male Contraceptive Targeting Meiosis
In a landmark development for reproductive medicine, researchers at Cornell University have announced a significant breakthrough in the quest for…
Read More
Contraline Secures $92.5 Million in Series B Funding to Advance Reversible Male Contraceptive to Late-Stage Clinical Trials
Contraline, a pioneering biotechnology firm backed by Google Ventures, has successfully closed a substantial $92.5 million Series B financing round.…
Read More
Cornell University Scientists Identify Novel Pathway for Safe and Reversible Nonhormonal Male Contraception Through Meiotic Inhibition
The pursuit of a reliable, reversible, and nonhormonal male contraceptive has long been described by the medical community as the…
Read More
Cornell University Scientists Develop Breakthrough Reversible Nonhormonal Male Contraceptive Through Targeted Meiotic Disruption
In a significant advancement for reproductive medicine, a team of researchers at Cornell University has announced a major breakthrough in…
Read More
Cornell University Researchers Achieve Milestone in Developing Reversible Nonhormonal Male Contraceptive Targeting Meiosis
The pursuit of a reliable, reversible, and nonhormonal male contraceptive has long been described by the medical community as the…
Read More
Cornell University Scientists Identify Potential Pathway for Reversible Non-Hormonal Male Contraceptive Targeting Meiosis
Researchers at Cornell University have announced a significant breakthrough in reproductive science, successfully demonstrating a method for a safe, reversible,…
Read More
Cornell University scientists develop a safe reversible and long-acting nonhormonal male contraceptive through targeted meiotic disruption
Researchers at Cornell University have announced a significant breakthrough in reproductive science, successfully demonstrating a method for nonhormonal male contraception…
Read More
